ArticleJournal of pharmacy & bioallied sciences2025
Optimizing Assisted Reproductive Outcomes using a Sperm Vitrification Device in severe Oligozoospermia: A Breakthrough in Male Infertility Treatment.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case study highlights the effective management of severe oligozoospermia using innovative sperm vitrification techniques. A 32-year-old woman and her 38-year-old husband sought treatment for primary infertility after three years of unsuccessful attempts to conceive. The male partner was diagnosed with severe oligozoospermia, which means having a low sperm count of 2 million/ml progressive motility and abnormal morphology. Advanced vitrification technology was employed to preserve 13 viable spermatozoa. The female partner's hormonal profile was normal with no reproductive issues, and she underwent ovarian stimulation, leading to the retrieval of 12 mature oocytes. After thawing, 10 spermatozoa were used for ICSI, achieving fertilization in six oocytes. Two blastocysts were transferred, while the remaining were cryopreserved for future attempts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.